Full Text Journal Articles by
Author Sandra L Kane Gill

Advertisement

Find full text journal articles






SCCM/ACCM Guideline and Toolkit Development Pathways.

Sandra L Kane-Gill, Julie Winkle, Lewis J Kaplan, Vinay Nadkarni, Lauren R Sorce, Lori Harmon, Greg S Martin,

Crit Care Med (Critical care medicine)
[2021, 49(11):1851-1854]

Cited: 0 times

View full text PDF listing >>



The Evolution of Toolkits and Bundles to Improve the Care of Sepsis Patients.

Greg S Martin, Sandra L Kane-Gill, Vinay Nadkarni, Lauren R Sorce, Lewis J Kaplan, Maurizio Cecconi, Elie Azoulay, Jean-Louis Teboul, Lui Forni, Jozef Kesecioglu,

Crit Care Med (Critical care medicine)
[2021, 49(11):1849-1850]

Cited: 0 times

View full text PDF listing >>



Advertisement

Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic: A Global Time Series Study.

Katherine Callaway Kim, Mina Tadrous, Sandra L Kane-Gill, Ian J Barbash, Scott Rothenberger, Katie J Suda,

<h4>Background</h4>Drug supply disruptions have increased during the COVID-19 pandemic, especially for medicines used in the ICU. Despite reported shortages in wealthy countries, global analyses of ICU drug purchasing during COVID-19 are limited.<h4>Research question</h4>Has COVID-19 impacted global drug purchases of first-, second-, and third-choice agents used in intensive care?<h4>Study design and ... Read more >>

Chest (Chest)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Feasibility of an Academic Detailing Intervention to Support Deprescribing in the Nursing Home.

Jennifer A Pruskowski, Sandra L Kane-Gill, Dio Kavalieratos, Brian K Wilson, Robert M Arnold, Steven M Handler,

J Am Med Dir Assoc (Journal of the American Medical Directors Association)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database.

Hyunwoo Kim, Colin M Pfeiffer, Matthew P Gray, Britney A Stottlemyer, Richard D Boyce, Sandra L Kane-Gill,

<h4>Background</h4>Between 2012 and 2017, 25 new medications or combination products were approved by the Food and Drug Administration (FDA) for use in treatment of chronic lower respiratory diseases (CLRDs). With limited data on post-marketing patient exposure to these drugs, their safety profiles remain unknown. This study aims to provide post-marketing ... Read more >>

Respir Care (Respiratory care)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Development of a Theory-Informed Behavior Change Intervention to Reduce Inappropriate Prescribing of Nephrotoxins and Renally Eliminated Drugs.

Sandra L Kane-Gill, Erin F Barreto, Azra Bihorac, John A Kellum,

<h4>Background</h4>Goals of managing patients with acute kidney injury (AKI) are mitigating disease progression and ensuring safety while providing supportive care because no effective treatment exists. One strategy recommended in guidelines to meet these goals is optimizing medication management. Unfortunately, guideline implementation appears to be lacking as observed by the frequent ... Read more >>

Ann Pharmacother (The Annals of pharmacotherapy)
[2021, :10600280211009567]

Cited: 0 times

View full text PDF listing >>



Key Roles for Pharmacists in Family-Centered Care to Advance Patient Safety.

Sandra L Kane-Gill, Lewis J Kaplan,

Crit Care Med (Critical care medicine)
[2021, 49(4):e454-e455]

Cited: 0 times

View full text PDF listing >>



A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.

Niti M Patel, Britney A Stottlemyer, Matthew P Gray, Richard D Boyce, Sandra L Kane-Gill,

<h4>Purpose</h4>Between 2012 and 2017, the FDA approved 29 therapies for a cardiovascular disease (CVD) indication. Due to the limited literature on patient safety outcomes for recently approved CVD medications, this study investigated adverse drug reports (ADRs) reported in the FDA Adverse Event Reporting System (FAERS).<h4>Methods</h4>A disproportionality analysis of spontaneously reported ... Read more >>

Cardiovasc Drugs Ther (Cardiovascular drugs and therapy)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Nephrotoxin Stewardship.

Sandra L Kane-Gill,

Drugs are the third leading cause of acute kidney injury (AKI) in critically ill patients. Nephrotoxin stewardship ensures a structured and consistent approach to safe medication use and prevention of patient harm. Comprehensive nephrotoxin stewardship requires coordinated patient care management strategies for safe medication use, ensuring kidney health, and avoiding ... Read more >>

Crit Care Clin (Critical care clinics)
[2021, 37(2):303-320]

Cited: 0 times

View full text PDF listing >>



A systematic review of cost-effectiveness analyses across the acute kidney injury landscape.

Kangho Suh, John A Kellum, Sandra L Kane-Gill,

<b>Introduction</b>: Acute kidney injury (AKI) is a complex and common condition associated with increased morbidity, mortality, and costs. Evidence from cost-effectiveness analysis (CEA) have targeted various aspects of AKI including detection with biomarkers, treatment with renal replacement therapy, and prevention when using contrast media. However, there has not been a ... Read more >>

Expert Rev Pharmacoecon Outcomes Res (Expert review of pharmacoeconomics & outcomes research)
[2021, 21(4):571-578]

Cited: 1 time

View full text PDF listing >>



Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.

Lindsay N Moreland-Head, James C Coons, Amy L Seybert, Matthew P Gray, Sandra L Kane-Gill,

<h4>Introduction</h4>Drug-induced QT<sub>c</sub>-prolongation is a well-known adverse drug reaction (ADR), however there is limited knowledge of other drug-induced arrhythmias.<h4>Purpose</h4>The objective of this study is to determine the drugs reported to be associated with arrhythmias other than QT<sub>c</sub>-prolongation using the FAERS database, possibly identifying potential drug causes that have not been reported ... Read more >>

J Cardiovasc Pharmacol Ther (Journal of cardiovascular pharmacology and therapeutics)
[2021, 26(4):341-348]

Cited: 1 time

View full text PDF listing >>



Biomarker-guided management of acute kidney injury.

Sandra L Kane-Gill, Melanie Meersch, Max Bell,

<h4>Purpose of review</h4>The current narrative review discusses practical applications of stress and damage biomarkers for the management of acute kidney injury (AKI) based on clinical trials and real-world evaluations.<h4>Recent findings</h4>In 2013 with the discovery and validation study of biomarkers for AKI (Sapphire) advancement in care was provided allowing for the ... Read more >>

Curr Opin Crit Care (Current opinion in critical care)
[2020, 26(6):556-562]

Cited: 3 times

View full text PDF listing >>



Transforming the Medication Regimen Review Process Using Telemedicine to Prevent Adverse Events.

Sandra L Kane-Gill, Adrian Wong, Colleen M Culley, Subashan Perera, Maureen D Reynolds, Steven M Handler, John A Kellum, Monica B Aspinall, Megan E Pellett, Keith E Long, David A Nace, Richard D Boyce,

<h4>Background/objectives</h4>Federally-mandated consultant pharmacist-conducted retrospective medication regimen reviews (MRRs) are designed to improve medication safety in nursing homes (NH). However, MRRs are potentially ineffective. A new model of care that improves access to and efficiency of consultant pharmacists is needed. The objective of this study was to determine the impact of ... Read more >>

J Am Geriatr Soc (Journal of the American Geriatrics Society)
[2021, 69(2):530-538]

Cited: 0 times

View full text PDF listing >>



Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement.

Marlies Ostermann, Alexander Zarbock, Stuart Goldstein, Kianoush Kashani, Etienne Macedo, Raghavan Murugan, Max Bell, Lui Forni, Louis Guzzi, Michael Joannidis, Sandra L Kane-Gill, Mathieu Legrand, Ravindra Mehta, Patrick T Murray, Peter Pickkers, Mario Plebani, John Prowle, Zaccaria Ricci, Thomas Rimmelé, Mitchell Rosner, Andrew D Shaw, John A Kellum, Claudio Ronco,

<h4>Importance</h4>In the last decade, new biomarkers for acute kidney injury (AKI) have been identified and studied in clinical trials. Guidance is needed regarding how best to incorporate them into clinical practice.<h4>Objective</h4>To develop recommendations on AKI biomarkers based on existing data and expert consensus for practicing clinicians and researchers.<h4>Evidence review</h4>At the ... Read more >>

JAMA Netw Open (JAMA network open)
[2020, 3(10):e2019209]

Cited: 15 times

View full text PDF listing >>



A Systemwide Approach for Navigating the Dilemma of Oral Factor Xa Inhibitor Interference With Unfractionated Heparin Anti-Factor Xa Concentrations.

Marissa N Levito, James C Coons, Margaret M Verrico, Adrienne Szymkowiak, Brianna Legler, Eric J Dueweke, Sandra L Kane-Gill,

<h4>Background</h4>Oral factor Xa inhibitors are known to significantly increase heparin anti-Xa concentrations, which leads to inaccuracies when monitoring intravenous unfractionated heparin (IV UFH). Guidance for managing this laboratory interference is lacking, creating substantial uncertainty in clinical practice.<h4>Objective</h4>To describe a strategy used by a large academic institution for managing the controversy ... Read more >>

Ann Pharmacother (The Annals of pharmacotherapy)
[2021, 55(5):618-623]

Cited: 0 times

View full text PDF listing >>



Coronavirus Disease 2019 Pandemic Measures: Reports From a National Survey of 9,120 ICU Clinicians.

Ruth Kleinpell, David M Ferraro, Ryan C Maves, Sandra L Kane Gill, Richard Branson, Steven Greenberg, Jennifer K Doersam, Rameela Raman, Lewis J Kaplan,

<h4>Importance</h4>Recent reports identify that among hospitalized coronavirus disease 2019 patients, 30% require ICU care. Understanding ICU resource needs remains an essential component of meeting current and projected needs of critically ill coronavirus disease 2019 patients.<h4>Objectives</h4>This study queried U.S. ICU clinician perspectives on challenging aspects of care in managing coronavirus disease ... Read more >>

Crit Care Med (Critical care medicine)
[2020, 48(10):e846-e855]

Cited: 8 times

View full text PDF listing >>



Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages.

Mahmoud A Ammar, Gretchen L Sacha, Sarah C Welch, Stephanie N Bass, Sandra L Kane-Gill, Abhijit Duggal, Abdalla A Ammar,

The rapid spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a global pandemic. The 2019 coronavirus disease (COVID-19) presents with a spectrum of symptoms ranging from mild to critical illness requiring intensive care unit (ICU) admission. Acute respiratory distress syndrome is a major complication in patients ... Read more >>

J Intensive Care Med (Journal of intensive care medicine)
[2021, 36(2):157-174]

Cited: 11 times

View full text PDF listing >>



A Conceptual Framework to Study the Implementation of Clinical Decision Support Systems (BEAR): Literature Review and Concept Mapping.

Jhon Camacho, Manuela Zanoletti-Mannello, Zach Landis-Lewis, Sandra L Kane-Gill, Richard D Boyce,

<h4>Background</h4>The implementation of clinical decision support systems (CDSSs) as an intervention to foster clinical practice change is affected by many factors. Key factors include those associated with behavioral change and those associated with technology acceptance. However, the literature regarding these subjects is fragmented and originates from two traditionally separate disciplines: ... Read more >>

J Med Internet Res (Journal of medical Internet research)
[2020, 22(8):e18388]

Cited: 1 time

View full text PDF listing >>



Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years.

Christian A Andreaggi, Emily A Novak, Mitchell E Mirabile, Shivani Sampathkumar, Matthew P Gray, Meiqi He, Sandra L Kane-Gill,

To perform an in-depth analysis of opioid-related ADRs reported by consumers, manufacturers and healthcare professionals. Delving into the depth and breadth of reported opioid-related adverse drug reactions (ADRs) provides an opportunity to strategize better clinical management and alleviate safety concerns. Retrospective pharmacovigilance disproportionality analysis for opioid-related ADRs in the FDA ... Read more >>

Pharmacoepidemiol Drug Saf (Pharmacoepidemiology and drug safety)
[2020, 29(12):1627-1635]

Cited: 0 times

View full text PDF listing >>



Benefits of Patient/Caregiver Engagement in Adverse Drug Reaction Reporting Compared With Other Sources of Reporting in the Inpatient Setting: A Systematic Review.

Dhanuvarshini Prakasam, Adrian L Wong, Pamela L Smithburger, Mitchell S Buckley, Sandra L Kane-Gill,

<h4>Objectives</h4>Clinicians learn from prior adverse events through pharmacovigilance allowing for improved medication safety in the medication use process; therefore, adverse drug reaction (ADR) reporting needs to be maximized. This systematic review was conducted to determine whether engaging patients/caregivers in ADR reporting during a patient's hospitalization provides further information about ADRs ... Read more >>

J Patient Saf (Journal of patient safety)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Dexmedetomidine for Facilitating Mechanical Ventilation Extubation in Difficult-to-Wean ICU Patients: Systematic Review and Meta-Analysis of Clinical Trials.

Mitchell S Buckley, Pamela L Smithburger, Adrian Wong, Gilles L Fraser, Michael C Reade, Michele Klein-Fedyshin, Thomas Ardiles, Sandra L Kane-Gill,

<h4>Background</h4>Agitation and delirium are common in mechanically ventilated adult intensive care unit (ICU) patients and may contribute to delayed extubation times. Difficult-to-wean ICU patients have been associated with an increased risk of longer ICU length of stays and mortality. The purpose of this systematic review and meta-analysis is to evaluate ... Read more >>

J Intensive Care Med (Journal of intensive care medicine)
[2021, 36(8):925-936]

Cited: 1 time

View full text PDF listing >>



Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.

Marlies Ostermann, Rinaldo Bellomo, Emmanuel A Burdmann, Kent Doi, Zoltan H Endre, Stuart L Goldstein, Sandra L Kane-Gill, Kathleen D Liu, John R Prowle, Andrew D Shaw, Nattachai Srisawat, Michael Cheung, Michel Jadoul, Wolfgang C Winkelmayer, John A Kellum, ,

In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) published a guideline on the classification and management of acute kidney injury (AKI). The guideline was derived from evidence available through February 2011. Since then, new evidence has emerged that has important implications for clinical practice in diagnosing and managing AKI. In ... Read more >>

Kidney Int (Kidney international)
[2020, 98(2):294-309]

Cited: 21 times

View full text PDF listing >>



Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM.

Richard G Wunderink, Arjun Srinivasan, Philip S Barie, Jean Chastre, Charles S Dela Cruz, Ivor S Douglas, Margaret Ecklund, Scott E Evans, Scott R Evans, Anthony T Gerlach, Lauri A Hicks, Michael Howell, Melissa L Hutchinson, Robert C Hyzy, Sandra L Kane-Gill, Erika D Lease, Mark L Metersky, Nancy Munro, Michael S Niederman, Marcos I Restrepo, Curtis N Sessler, Steven Q Simpson, Sandra M Swoboda, Christina Vazquez Guillamet, Grant W Waterer, Curtis H Weiss,

Intensive care units (ICUs) are an appropriate focus of antibiotic stewardship program efforts because a large proportion of any hospital's use of parenteral antibiotics, especially broad-spectrum, occurs in the ICU. Given the importance of antibiotic stewardship for critically ill patients and the importance of critical care practitioners as the front ... Read more >>

Ann Am Thorac Soc (Annals of the American Thoracic Society)
[2020, 17(5):531-540]

Cited: 4 times

View full text PDF listing >>



Patient-Reported Outcomes Associated With Sedation and Agitation Intensity in the Critically Ill.

Ashleigh Malinowski, Neal J Benedict, Meng-Ni Ho, Levent Kirisci, Sandra L Kane-Gill,

<h4>Background</h4>Patient-reported outcomes are essential to understand the relationship between patients' perception of sedation and clinicians' assessments of sedation.<h4>Objectives</h4>To evaluate the association between sedation and agitation indexes and patient-reported outcomes of sedation and analgesia.<h4>Methods</h4>This prospective, single-center, observational study included adult patients who were continuously sedated for at least 24 hours in ... Read more >>

Am J Crit Care (American journal of critical care : an official publication, American Association of Critical-Care Nurses)
[2020, 29(2):140-144]

Cited: 0 times

View full text PDF listing >>



Use of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor binding protein 7 [TIMP2]•[IGFBP7] as an AKI risk screening tool to manage patients in the real-world setting.

Sandra L Kane-Gill, Sadudee Peerapornratana, Adrian Wong, Raghavan Murugan, Lara M Groetzinger, Catherine Kim, Pamela L Smithburger, Janine Then, John A Kellum,

<h4>Purpose</h4>To determine the application of various components of the Kidney Disease Improving Global Outcomes (KDIGO) bundle in managing patients at high-risk for AKI progression ([TIMP2]•[IGFBP7] >0.3) in the real-world setting.<h4>Methods</h4>Patients with a [TIMP2]•[IGFBP7] test ordered between 5/23/16-2/28/18 were evaluated. We reviewed the medical record for evidence of implementation of the ... Read more >>

J Crit Care (Journal of critical care)
[2020, 57:97-101]

Cited: 1 time

View full text PDF listing >>



Advertisement


Disclaimer

1.0607 s